Bio Essence Corporation
BIOE
$0.05
-$0.01-10.96%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.12% | -132.59% | -150.13% | -34.69% | -48.79% |
| Total Depreciation and Amortization | 102.04% | 104.55% | -70.37% | -74.47% | -349.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.65% | 15,062.35% | 8,204.09% | 452.38% | 332.90% |
| Change in Net Operating Assets | 152.17% | 1,193.69% | 452.82% | 414.80% | 242.63% |
| Cash from Operations | 22,881.82% | 230.73% | 179.69% | 160.83% | 99.65% |
| Capital Expenditure | -- | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.89% | 99.89% | 99.89% | 99.89% | -865.93% |
| Total Debt Issued | 0.26% | -35.09% | -59.66% | -73.70% | -38.57% |
| Total Debt Repaid | -221.85% | -3,556.88% | -11,443.93% | -70,946.15% | -1,471.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | 86.34% | -1,014.74% |
| Cash from Financing | -722.15% | -215.59% | -172.79% | -156.03% | -87.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.35% | -206.59% | -- | 119.67% | 6,080.00% |